HomeM&M › Filing
🔔 Get instant alerts when M&M files quarterly results on BSE Start free trial →

Please find the enclosed file.

Filed: 12 Feb 2026, 00:00 IST Exchange: BSE Category: General Update — Product Launch
Mahindra Last Mile Mobility launched the Mahindra UDO e-auto priced at ₹3,84,299 ex-showroom, with a limited period offer at ₹3,58,999. The L5 M e-auto features airplane-inspired design, full monocoque construction, and best-in-class 200 km real-world range. It offers superior comfort with a pilot seat and first-class passenger seating, tri-mode driving system, and advanced safety features including powerful drum brakes and IP67-rated battery. Manufactured at Zaheerabad plant with Rs. 218 crore investment funded by internal accruals.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 M&M — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add M&M to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Mahindra Mahindra Ltd

Important. The summary above is generated automatically from Mahindra Mahindra Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.